GDC is part of the Informa Tech Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

GDC + VRDC 2019 Session Scheduler

View, browse and sort the ever-growing list of GDC sessions by pass type, track, format, and more! With Session Scheduler, create an account to build your own GDC schedule and access it anywhere, including on the GDC app, once live.

If you've registered for GDC, you can use the same login credentials. Adding a session to your schedule does not guarantee you a seat. Sessions do fill up, so please arrive early to sessions that you would like to attend.

Pain Medication Reimagined: VR for Chronic Pain

David Putrino  (Assistant Professor, Icahn School of Medicine at Mount Sinai)

Location: Room 210, South Hall

Date: Tuesday, March 19

Time: 3:00 pm - 3:30 pm

Pass Type: All Access, VRDC Add On - Get your pass now!

Topic: Game VR/AR

Format: Session

Vault Recording: Video

Audience Level: All

Neuropathic pain is a debilitating form of chronic pain that is associated with decreased quality of life, depression, drug abuse and suicidal risk. It affects 48 million people worldwide. There is emerging evidence to suggest that virtual reality may be a viable, low-cost and low-risk therapy for treating and managing neuropathic pain. This presentation will detail some of the ways that virtual reality environments are being developed and validated as therapies for chronic pain rehabilitation for people with spinal cord injury, traumatic brain injury, diabetes and HIV.


Following this presentation, attendees will get a working explanation of the neurophysiology underlying how virtual reality therapy can create substantive brain changes in users. They will also gain insights into the design of virtual reality environments that can produce pain-relieving responses in people who are living with chronic pain.

Intended Audience

The intended audience for this presentation is general. There will be no prerequisite knowledge required to follow the content. It is most likely to be of interest to people who have an interest in understanding how to use technology for therapeutic, medical and humanitarian causes.